marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Greenwich LifeSciences Balance Sheet 2011-2024 | GLSI
Annual Balance Sheet Greenwich LifeSciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -28.7 K | -6.84 K | -85.1 K | - | - | - | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 9.5 M | - | - | - | - | - | - | - |
Total Current Liabilities |
294 K | 263 K | 385 K | 1.05 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
294 K | 263 K | 385 K | 1.05 K | 1.38 M | 10.2 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-50.4 M | -41.5 M | -33.6 M | - | -27.2 M | -23.8 M | - | - | - | - | - | - | - |
Total Assets |
6.99 M | 13.5 M | 27.2 M | 28.7 K | 26.7 K | 109 K | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
6.99 M | 13.5 M | 27.2 M | 28.7 M | - | - | - | - | - | - | - | - | - |
Book Value |
6.7 M | 13.2 M | 26.8 M | 27.6 K | -1.35 M | -10.1 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
6.7 M | 13.2 M | 26.8 M | 27.6 M | -1.35 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Greenwich LifeSciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
842 K | 1.35 M | 390 K | 294 K | 297 K | 302 K | 236 K | 263 K | 238 K | 229 K | 241 K | 385 K | 455 K | 653 K | 673 K | 1.05 M | 1.05 M | 1.05 M | 1.05 M | 1.38 M | 1.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-58.1 M | -55.4 M | -52.8 M | -50.4 M | -47.6 M | -45.2 M | -43.6 M | -41.5 M | -38.7 M | -36.4 M | -35.6 M | -33.6 M | -31.3 M | -30.4 M | -29.7 M | -29.1 M | -29.1 M | -29.1 M | -29.1 M | -27.2 M | -27.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
5.83 M | 7.23 M | 5.51 M | 6.99 M | 9.15 M | 11 M | 11.9 M | 13.5 M | 15.6 M | 17.2 M | 19.8 M | 27.2 M | 28.9 M | 29.8 M | 30.4 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 26.7 K | 26.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
5.82 M | 7.22 M | 5.51 M | 6.99 M | 9.14 M | 10.9 M | 11.9 M | 13.5 M | 15.6 M | 17.2 M | 19.7 M | 27.2 M | 28.9 M | 29.8 M | 30.4 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 6.84 K | 6.84 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
4.98 M | 5.88 M | 5.12 M | 6.7 M | 8.85 M | 10.6 M | 11.7 M | 13.2 M | 15.4 M | 17 M | 19.5 M | 26.8 M | 28.5 M | 29.2 M | 29.7 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | -1.35 M | -1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
4.98 M | 5.88 M | 5.12 M | 6.7 M | 8.85 M | 10.6 M | 11.7 M | 13.2 M | 15.4 M | 17 M | 19.5 M | 26.8 M | 28.5 M | 29.2 M | 29.7 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | -1.35 M | -1.35 M | -12.9 M | -10.3 M | -10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency